Suppr超能文献

非瓣膜性心房颤动:血栓前状态的证据。

Nonvalvular atrial fibrillation: evidence for a prothrombotic state.

作者信息

Kahn S R, Solymoss S, Flegel K M

机构信息

Division of General Internal Medicine, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Que.

出版信息

CMAJ. 1997 Sep 15;157(6):673-81.

Abstract

OBJECTIVE

To determine whether patients with nonvalvular atrial fibrillation (NVAF) have prothrombotic changes compared with patients in sinus rhythm.

DESIGN

Cross-sectional study. Hemostatic function compared in NVAF patients without prior embolic event (transient ischemic attack or embolic stroke) and control subjects without prior thrombotic stroke, and in NVAF patients with prior embolic event and control subjects with prior thrombotic stroke.

SETTING

Internal medicine outpatient group practice and anticoagulation clinic in 2 teaching hospitals.

PATIENTS

A total of 75 NVAF patients (50 without and 25 with prior embolic event) and 42 control patients (31 without and 11 with prior thrombotic stroke) recruited concurrently over 18 months during 1990-91.

OUTCOME MEASURES

Platelet count, prothrombin time (PT), partial thromboplastin time (PTT), and plasma levels of hemoglobin, fibrinogen, von Willebrand factor antigen, factor VIII, fibrin D-dimer, antithrombin III, protein C, protein S, fibrinopeptide A and prothrombin fragment F1+2. All statistical analyses were performed after adjustments for age and sex.

RESULTS

The NVAF patients without a prior embolic event had significantly higher mean hemoglobin and fibrinogen levels (p < 0.001 and p = 0.05, respectively) than the control subjects without prior thrombotic stroke. The 29 NVAF patients not taking warfarin (none had had an embolic event) had significantly lower mean protein C and protein S levels (p = 0.012 and p < 0.001, respectively) and a significantly higher fibrinopeptide A level (p = 0.03, after exclusion of outliers) than the control subjects without prior stroke. The NVAF patients with a prior embolic event had alterations in the hemostatic variables similar to those seen in the control patients with a prior thrombotic stroke. The latter had significantly higher fibrinogen, von Willebrand factor antigen and factor VIII levels (p = 0.04, 0.002 and 0.002, respectively) and significantly lower protein S levels (p = 0.02) than the control subjects without prior stroke.

CONCLUSIONS

NVAF patients without a history of an embolic event show evidence of a prothrombotic state compared with patients in sinus rhythm who have not had a thrombotic stroke. NVAF patients with a history of an embolic event show evidence of a prothrombotic state similar to that of patients in sinus rhythm who have had a thrombotic stroke. Prospective studies are needed to determine whether these abnormalities predict higher risk of stroke in individual NVAF patients.

摘要

目的

确定与窦性心律患者相比,非瓣膜性心房颤动(NVAF)患者是否存在血栓前状态的改变。

设计

横断面研究。比较无既往栓塞事件(短暂性脑缺血发作或栓塞性卒中)的NVAF患者与无既往血栓性卒中的对照受试者,以及有既往栓塞事件的NVAF患者与有既往血栓性卒中的对照受试者的止血功能。

地点

两家教学医院的内科门诊小组诊所和抗凝门诊。

患者

1990年至1991年期间,在18个月内同时招募了75例NVAF患者(50例无既往栓塞事件,25例有既往栓塞事件)和42例对照患者(31例无既往血栓性卒中,11例有既往血栓性卒中)。

观察指标

血小板计数、凝血酶原时间(PT)、部分凝血活酶时间(PTT)以及血红蛋白、纤维蛋白原、血管性血友病因子抗原、因子VIII、纤维蛋白D-二聚体、抗凝血酶III、蛋白C、蛋白S、纤维肽A和凝血酶原片段F1+2的血浆水平。所有统计分析均在对年龄和性别进行调整后进行。

结果

无既往栓塞事件的NVAF患者的平均血红蛋白和纤维蛋白原水平显著高于无既往血栓性卒中的对照受试者(分别为p < 0.001和p = 0.05)。29例未服用华法林的NVAF患者(均无栓塞事件)的平均蛋白C和蛋白S水平显著低于无既往卒中的对照受试者(分别为p = 0.012和p < 0.001),纤维肽A水平显著高于对照受试者(排除异常值后p = 0.03)。有既往栓塞事件的NVAF患者的止血变量改变与有既往血栓性卒中的对照患者相似。后者的纤维蛋白原、血管性血友病因子抗原和因子VIII水平显著高于无既往卒中的对照受试者(分别为p = 0.04、0.002和0.002),蛋白S水平显著低于对照受试者(p = 0.02)。

结论

与无血栓性卒中的窦性心律患者相比,无栓塞事件病史的NVAF患者显示出血栓前状态的证据。有栓塞事件病史的NVAF患者显示出与有血栓性卒中的窦性心律患者相似的血栓前状态的证据。需要进行前瞻性研究以确定这些异常是否预示个体NVAF患者发生卒中的风险更高。

相似文献

3
Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Int J Cardiol. 2008 Jun 6;126(3):316-21. doi: 10.1016/j.ijcard.2007.06.020. Epub 2007 Aug 8.
4
D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Int J Cardiol. 2006 Apr 28;109(1):59-65. doi: 10.1016/j.ijcard.2005.05.049. Epub 2005 Jul 1.
6
Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
J Gastroenterol Hepatol. 2010 Jan;25(1):116-21. doi: 10.1111/j.1440-1746.2009.05921.x. Epub 2009 Aug 3.
7
Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
J Am Coll Cardiol. 2004 Jun 2;43(11):2075-82. doi: 10.1016/j.jacc.2003.11.062.
9
Analysis of coagulation parameters in the early period after kidney transplantation.
Transplant Proc. 2007 Nov;39(9):2754-5. doi: 10.1016/j.transproceed.2007.08.050.

引用本文的文献

1
Association between venous thromboembolism and atrial fibrillation: a Mendelian randomization study.
BMC Med Genomics. 2024 Oct 29;17(1):258. doi: 10.1186/s12920-024-02034-y.
4
Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
Biomed Res Int. 2017;2017:3678017. doi: 10.1155/2017/3678017. Epub 2017 Jun 21.
6
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.
Circ Res. 2017 Apr 28;120(9):1501-1517. doi: 10.1161/CIRCRESAHA.117.309732.
10
Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.
J Atr Fibrillation. 2014 Dec 31;7(4):1124. doi: 10.4022/jafib.1124. eCollection 2014 Dec.

本文引用的文献

3
Hemostatic markers in acute transient ischemic attacks.
Stroke. 1994 Feb;25(2):282-6. doi: 10.1161/01.str.25.2.282.
8
Red blood cells: their dual role in thrombus formation.
Science. 1980 Feb 1;207(4430):541-3. doi: 10.1126/science.7352265.
10
Coronary heart disease and atrial fibrillation: the Framingham Study.
Am Heart J. 1983 Aug;106(2):389-96. doi: 10.1016/0002-8703(83)90208-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验